Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 172 publications
TWSG1 variation identifies a ustekinumab-response phenotype in patients with inflammatory bowel disease.
Journal: Pharmacogenetics and genomics
Published: April 21, 2026
In Memoriam: Brian G. Feagan, MD, FRCPC (1954-2025).
Journal: Gastroenterology
Published: April 12, 2026
In Memoriam: Brian G. Feagan, MD, FRCPC (1954-2025).
Journal: Gastroenterology
Published: February 13, 2026
Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study.
Journal: Clinical and translational gastroenterology
Published: August 07, 2025
Global Incidence and Prevalence of Inflammatory Bowel Disease Over Time.
Journal: Gastroenterology
Published: July 20, 2025
The Power of Precision: Unravelling the Radiobiology of Targeted Radionuclide Therapy.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: June 13, 2025
IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-α-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.
Journal: Alimentary pharmacology & therapeutics
Published: May 28, 2025
Development and validation of a novel Endoscopic ulcer Activity Score for Evaluation of Crohn's Disease (EASE-CD) using data from two randomised controlled trials.
Journal: The lancet. Gastroenterology & hepatology
Published: December 02, 2024
The Clinical Interpretation of Cluster Trials.
Journal: Inflammatory bowel diseases
Published: October 05, 2024
Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis.
Journal: Gastroenterology
Published: August 29, 2024
A Head-to-Head Comparison of Risankizumab and Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn's Disease.
Journal: Gastroenterology
Published: August 29, 2024
Last Updated: 09/26/2026